World Health Organization

Slides:



Advertisements
Similar presentations
Overview of HPV vaccination Training GardasilTM
Advertisements

Module 3 Rotavirus vaccine eligibility
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility.
A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should.
Module 3 Inactivated poliovirus vaccine eligibility Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Training for rotavirus vaccine introduction Module 5 Recording and monitoring uptake of rotavirus vaccine.
Module 5 Recording and monitoring uptake of Inactivated Polio vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Training for rotavirus vaccine introduction Module 3 Rotavirus vaccine eligibility.
Preparing for Vaccine Administration: Warnings, Precautions and Contraindications Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious.
Training for rotavirus vaccine introduction Module 1 Introduction to rotavirus disease and vaccine.
Module 3 IPV schedule, eligibility and contraindications Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Module 5 Recording and monitoring administration of the Inactivated Polio Vaccine (IPV) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP
Module 5 Recording and monitoring uptake of rotavirus vaccine
Fractional IPV (fIPV) eligibility
HPV VACCINES Dr. Kirtan Krishna.
Module 4 HPV vaccine administration GardasilTM
Module 6 Communicating about HPV Vaccine with Stakeholders CervarixTM
Module 4 HPV vaccine administration CervarixTM
Module 5 Recording and monitoring of HPV vaccine GardasilTM
Module 5 Recording and monitoring of HPV vaccine CervarixTM
Module 7 Communicating about CD-JEV vaccine with caregivers
Module 6 Communicating about HPV Vaccine with Stakeholders CervarixTM
Module 6 Communicating about HPV Vaccine with Stakeholders GardasilTM
World Health Organization
Safety and acceptability of multiple injections
Communicating with caregivers about IPV and multiple injections
World Health Organization
Communicating with caregivers about IPV and multiple injections
World Health Organization
World Health Organization
Module 6 Communicating about HPV Vaccine with Stakeholders CervarixTM
Recording and monitoring uptake of JE vaccine
World Health Organization
World Health Organization
Module 6 Rotavirus vaccine AEFI monitoring
Module 5 Recording and monitoring of HPV vaccine GardasilTM
JE vaccine eligibility
World Health Organization
Recording and monitoring uptake of fractional IPV (fIPV)
Module 6 Communicating about HPV Vaccine with Stakeholders GardasilTM
Module 1 Introduction to rotavirus disease and vaccine
Module 1 Introduction to rotavirus disease and vaccine
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction
Module 4 HPV vaccine administration GardasilTM
World Health Organization
Module 1 Introduction to rotavirus disease and vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 6 Rotavirus vaccine AEFI monitoring
Module 6 Rotavirus vaccine AEFI monitoring
Module 1 Introduction to rotavirus disease and vaccine
Module 5 Recording and monitoring of HPV vaccine CervarixTM
Training for rotavirus vaccine introduction
Module 4 HPV vaccine administration CervarixTM
Module 1 Introduction to rotavirus disease and vaccine
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 6 Communicating about HPV Vaccine with Stakeholders GardasilTM
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
Module 5 Recording and monitoring uptake of rotavirus vaccine
The National Cervical Screening Programme
Module 3 Rotavirus vaccine eligibility
Training for rotavirus vaccine introduction
Training for rotavirus vaccine introduction
World Health Organization
Presentation transcript:

World Health Organization 24 November, 2019 Essential Training Package for HPV Vaccine Introduction Module 3 HPV vaccine eligibility and contraindications CervarixTM

Learning objectives At the end of the module, you will have learned to: Describe the recommended immunization schedule for CervarixTM Describe when a girl is eligible for HPV vaccine and when she is not eligible Describe the absolute contraindications for vaccination Duration 60’

Key issues 1 2 3 4 What is the schedule and dosage for CervarixTM? How do you determine a girl’s eligibility for HPV vaccine? 2 What to do when…? 3 What are the precautions and contraindications? 4 Explain to the participants the key issues raised in this module: What is the schedule and dosage for CervarixTM? How do you determine a girl’s eligibility for HPV vaccine? What to do when…? What are the precautions and contraindications?

What is the schedule for CervarixTM, vaccine administration? Example schedule Dose 1 Dose 2 Minimum interval of 6 months HPV vaccine, CervarixTM, is a 2 dose schedule with a minimum interval of 6 months between the first and second dose. Each dose is administered intramuscularly using 0.5ml of liquid suspension The second dose is at least 6 months after the first dose Attention: if second dose is administered too early (prior to 6 month interval) then a third dose will be needed to achieve full protection. The third dose should be given at least 6 months after the first dose

Who should get HPV vaccine?   Ask the audience to point to the image of girls who they think should get HPV vaccine. The answer will appear by a mouse click in animations. Pic 1: The target population for HPV vaccination are girls who are 9 – 13 years old Pic 2: The vaccines are not recommended for girls younger than 9 years of age For the HPV vaccine to work best, it is very important for preteens to get all 2 doses (shots) long before any sexual activity with another person begins. It is possible to be infected with HPV the very first time that a person has sexual contact with another person. Also, the vaccine produces higher antibody levels when given at early age compared to older ages

Are there contraindications to HPV vaccination? HPV vaccine is not recommended for: SEVERE FEBRILE ILLNESS Pic 1: HPV vaccines are not recommended for use in people who have experienced severe allergic reactions after a previous vaccine dose, or to a component of the vaccine (for example, yeast in CervarixTM) Pic 2: HPV vaccines are not recommended for use in pregnancy. If a girl becomes pregnant after initiating the vaccination series, the remainder of the 2-dose regime should be delayed until after completion of the pregnancy. In the event that the HPV vaccine is inadvertently administered to a girl who is pregnant, no intervention is necessary. No health problems in mother or child have been observed to date after accidental HPV vaccination during pregnancy Pic 3: Girls with severe febrile illness should not be vaccinated A minor infection such as a cold is not a contraindication

What should you do in this scenario? The girl is pregnant when she returns for second dose of HPV vaccine. In the event that a girl is pregnant after initiating the vaccination series, the remainder of the 2 dose regimen should be delayed until after completion of the pregnancy.

What should you do in this scenario? The girl is immunocompromised due to HIV/AIDS. HPV vaccination is safe and immunogenic and does not cause problems for HIV-infected persons who get the vaccine. HPV vaccine is not contraindicated in HIV-infected girls. However, the immune response and vaccine efficacy might be less than in persons who are immunocompetent. Vaccinate as usual. Therefore, HIV-infected girls should be given 3 doses – following a 0, 1, 6 month schedule

What should you do in this scenario? The girl came in to an immunization session for her second dose. Ten months have passed since she received the first dose. Give the second dose of HPV vaccine.

Key messages CervarixTM is a 2 dose schedule, administered with a minimum interval of 6 months between 1st and 2nd dose: minimum interval of 6 months Girls between 9 and 13 years old are eligible for HPV vaccination Contrindications for HPV vaccination are: Allergy after a previous vaccine dose, or to a component of the vaccine Pregnancy Severe febrile illness For CervarixTM, a minimum interval of 6 months between the 1st and 2nd doses The target population for HPV vaccination are girls who are between 9 and 13 years old Contraindications for HPV vaccination are: Allergy after a previous vaccine dose, or to a component of the vaccine Pregnancy (delay vaccination until after the pregnancy) Severe febrile illness

End of module for your attention! Thank you This is the end of the module, thank you for your attention!

References Comprehensive Cervical Cancer Control. A guide to essential practice (C4 GEP). WHO 2014 HPV vaccine introduction into national immunization programmes: Information for programme managers and health workers. WHO 2014